Luri-Rey C, Teijeira A, Wculek S, de Andrea C, Herrero C, Lopez-Janeiro A
Nat Rev Cancer. 2025; .
PMID: 39881005
DOI: 10.1038/s41568-024-00785-5.
Singh S, Tehseen A, Dahiya S, Singh Y, Sarkar R, Sehrawat S
Nat Commun. 2024; 15(1):10300.
PMID: 39604443
PMC: 11603169.
DOI: 10.1038/s41467-024-54757-2.
Hsu J, Kim S, Anandasabapathy N
Viruses. 2024; 16(6).
PMID: 38932162
PMC: 11209207.
DOI: 10.3390/v16060870.
Sengupta D, Galicia-Pereyra R, Han P, Graham M, Liu X, Arshad N
J Immunol. 2024; 212(7):1063-1068.
PMID: 38353614
PMC: 10948299.
DOI: 10.4049/jimmunol.2200446.
Li Q
Front Cell Infect Microbiol. 2023; 13:1294082.
PMID: 38035341
PMC: 10684967.
DOI: 10.3389/fcimb.2023.1294082.
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.
Wijfjes Z, van Dalen F, Le Gall C, Verdoes M
Mol Pharm. 2023; 20(10):4826-4847.
PMID: 37721387
PMC: 10548474.
DOI: 10.1021/acs.molpharmaceut.3c00330.
Outside-in signaling through the major histocompatibility complex class-I cytoplasmic tail modulates glutamate receptor expression in neurons.
Eyford B, Lazarczyk M, Choi K, Varghese M, Arora H, Kari S
Sci Rep. 2023; 13(1):13079.
PMID: 37567897
PMC: 10421907.
DOI: 10.1038/s41598-023-38663-z.
Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions.
Li Y, Li S, Jiang Z, Tan K, Meng Y, Zhang D
J Nanobiotechnology. 2023; 21(1):212.
PMID: 37415161
PMC: 10327386.
DOI: 10.1186/s12951-023-01977-1.
Major histocompatibility complex class I assembly within endolysosomal pathways.
Olson E, Raghavan M
Curr Opin Immunol. 2023; 84:102356.
PMID: 37379719
PMC: 11759227.
DOI: 10.1016/j.coi.2023.102356.
Isolation of Polystyrene Bead-Induced Phagosomes for Western Blotting.
Raymond B, Inns J, Frey A, Trost M
Methods Mol Biol. 2023; 2692:237-246.
PMID: 37365472
DOI: 10.1007/978-1-0716-3338-0_16.
Channeling antigens to CD8 T cells.
Rawat K, Jakubzick C
Science. 2023; 380(6651):1218-1219.
PMID: 37347866
PMC: 10589910.
DOI: 10.1126/science.adi5711.
Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells.
Rodriguez-Silvestre P, Laub M, Krawczyk P, Davies A, Schessner J, Parveen R
Science. 2023; 380(6651):1258-1265.
PMID: 37347855
PMC: 7614779.
DOI: 10.1126/science.adg8802.
A Lysosome-Targeted Tetrazine for Organelle-Specific Click-to-Release Chemistry in Antigen Presenting Cells.
Ligthart N, de Geus M, van de Plassche M, Torres Garcia D, Isendoorn M, Reinalda L
J Am Chem Soc. 2023; 145(23):12630-12640.
PMID: 37269296
PMC: 10273227.
DOI: 10.1021/jacs.3c02139.
The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain.
Lazarczyk M, Eyford B, Varghese M, Arora H, Munro L, Warda T
Sci Rep. 2023; 13(1):6448.
PMID: 37081001
PMC: 10119172.
DOI: 10.1038/s41598-023-30054-8.
Gene Polymorphisms Increase the Susceptibility to Tuberculosis.
Lu T, Wang M, Liu N, Zhang S, Shi L, Bao L
Pharmgenomics Pers Med. 2023; 16:325-336.
PMID: 37077653
PMC: 10108862.
DOI: 10.2147/PGPM.S404339.
Pathways of MHC I cross-presentation of exogenous antigens.
Cruz F, Chan A, Rock K
Semin Immunol. 2023; 66:101729.
PMID: 36804685
PMC: 10023513.
DOI: 10.1016/j.smim.2023.101729.
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.
Blander J
Semin Immunol. 2023; 66:101713.
PMID: 36706521
PMC: 10023361.
DOI: 10.1016/j.smim.2023.101713.
The evolving biology of cross-presentation.
Ohara R, Murphy K
Semin Immunol. 2023; 66:101711.
PMID: 36645993
PMC: 10931539.
DOI: 10.1016/j.smim.2023.101711.
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.
Oliveira M, DAulerio R, Yong T, He M, Baptista M, Nylen S
Br J Cancer. 2023; 128(6):982-991.
PMID: 36631633
PMC: 10006228.
DOI: 10.1038/s41416-022-02135-4.
The E3 ubiquitin ligase RNF115 regulates phagosome maturation and host response to bacterial infection.
Bilkei-Gorzo O, Heunis T, Marin-Rubio J, Cianfanelli F, Raymond B, Inns J
EMBO J. 2022; 41(23):e108970.
PMID: 36281581
PMC: 9713710.
DOI: 10.15252/embj.2021108970.